Abstract
Refractory pituitary adenomas are difficult to control tumors that progress through optimal surgical, medical, and radiation management. Repeat surgery is a valuable tool to reduce tumor volume for more effective radiation and/or medical therapy, and to decompress critical neurovascular structures. Advances in surgical techniques and technologies, including minimally invasive cranial approaches, intraoperative MRI suites, and cranial nerve monitoring, have improved surgical outcomes and expanded indications. Today, repeat transsphenoidal surgery has similar complications rates to upfront surgery in historical cohorts. The decision to operate on refractory adenomas should be made with multidisciplinary teams, balancing the benefit of tumor reduction with the potential for complications, including cranial nerve injury, carotid injury, and cerebrospinal fluid leak.
Similar content being viewed by others
Data availability
not applicable as no datasets were used for development of this manuscript.
References
Delgado-López PD, Pi-Barrio J, Dueñas-Polo MT, Pascual-Llorente M, Gordón-Bolaños MC (2018) Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options. Clin Transl Oncol 20(10):1233–1245. https://doi.org/10.1007/s12094-018-1868-6
Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71–83. https://doi.org/10.1007/s11102-011-0347-7
Liu X, Dai C, Feng M, Li M, Chen G, Wang R (2021) Diagnosis and treatment of refractory pituitary adenomas: a narrative review. Gland Surg 10(4):1499–1507. https://doi.org/10.21037/gs-20-873
Forster N, Warnick R, Takiar V, Pater L, Breneman J (2018) Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery. J Neurooncol 138(2):335–340. https://doi.org/10.1007/s11060-018-2801-0
Guo S, Wang Z, Kang X, Xin W, Li X (2021) A Meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas: comparisons of efficacy and safety. Front Neurol 12(March):1–11. https://doi.org/10.3389/fneur.2021.614382
Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610–618. https://doi.org/10.1227/00006123-199310000-00008
Micko ASG, Wöhrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803–811. https://doi.org/10.3171/2014.12.JNS141083
Perry A, Graffeo CS, Meyer J et al (2019) Beyond the learning curve: comparison of microscopic and endoscopic Incidences of Internal Carotid Injury in a series of highly experienced operators. World Neurosurg 131:e128–e135. https://doi.org/10.1016/j.wneu.2019.07.074
van Westrhenen A, Muskens IS, Verhoeff JJC, Smith TRS, Broekman MLD (2017) Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review. J Neurooncol 135(1):1–11. https://doi.org/10.1007/s11060-017-2530-9
Gong X, Zhuo Y, Yuan H et al (2022) Outcome of endoscopic transsphenoidal surgery for recurrent or residual pituitary adenomas and comparison to non-recurrent or residual cohort by propensity score analysis. Front Endocrinol (Lausanne) 13(April):1–10. https://doi.org/10.3389/fendo.2022.837025
Ishida A, Shiramizu H, Yoshimoto H et al (2022) Resection of the Cavernous Sinus Medial Wall 00(00):1–7
Kalinin PL, Sharipov OI, Pronin IN et al (2016) Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus. Zh Vopr Neirokhir Im N N Burdenko 80(4):63–74. https://doi.org/10.17116/neiro201680463-74
Ouyang T, Zhang N, Xie S et al (2021) Outcomes and complications of aggressive resection strategy for Pituitary Adenomas in Knosp Grade 4 with Transsphenoidal Endoscopy. Front Oncol 11:693063. https://doi.org/10.3389/fonc.2021.693063
Kessler RA, Garzon-Muvdi T, Kim E, Ramanathan M, Lim M (2019) Utilization of the Nasoseptal flap for repair of Cerebrospinal Fluid Leak after Endoscopic Endonasal Approach for Resection of Pituitary Tumors. Brain Tumor Res Treat 7(1):10. https://doi.org/10.14791/btrt.2019.7.e19
Zwagerman NT, Wang EW, Shin SS et al Does lumbar drainage reduce postoperative cerebrospinal fluid leak after endoscopic endonasal skull base surgery? A prospective, randomized controlled trial.J Neurosurg. October2018:1–7. doi: https://doi.org/10.3171/2018.4.JNS172447
Kamimura K, Nakajo M, Bohara M et al (2021) Consistency of pituitary adenoma: prediction by pharmacokinetic dynamic contrast-enhanced mri and comparison with histologic collagen content. Cancers (Basel) 13(15). https://doi.org/10.3390/cancers13153914
Thirumala P, Mohanraj S, Habeych M et al (2013) Value of Free-Run Electromyographic monitoring of Extraocular cranial nerves during expanded endonasal surgery (EES) of the Skull Base. J Neurol Surg Reports 74(01):043–050. https://doi.org/10.1055/s-0033-1346975
Fernandez-Miranda JC, Zwagerman NT, Abhinav K et al (2018) Cavernous sinus compartments from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery. J Neurosurg 129(2):430–441. https://doi.org/10.3171/2017.2.JNS162214
Hayhurst C, Taylor PN, Lansdown AJ, Palaniappan N, Rees DA, Davies JS (2020) Current perspectives on recurrent pituitary adenoma: the role and timing of surgery vs adjuvant treatment. Clin Endocrinol (Oxf) 92(2):89–97. https://doi.org/10.1111/cen.14127
Park HH, Kim EH, Ku CR, Lee EJ, Kim SH (2018) Outcomes of Aggressive Surgical Resection in Growth hormone–secreting Pituitary Adenomas with Cavernous Sinus Invasion. World Neurosurg 117:e280–e289. https://doi.org/10.1016/j.wneu.2018.06.012
Vural A, Carobbio ALC, Ferrari M et al (2021) Correction to: transorbital endoscopic approaches to the skull base: a systematic literature review and anatomical description (neurosurgical review, (2021), 10.1007/s10143-020-01470-5). Neurosurg Rev 44(5):2943. https://doi.org/10.1007/s10143-021-01529-x
Fung K, Szeto C, Wehrli B et al (2011) Contact endoscopy as a novel technique in the detection and diagnosis of mucosal lesions in the head and neck: A brief review. J Oncol. ;2011. doi:https://doi.org/10.1155/2011/196302
Vergeer RA, Theunissen REP, van Elk T et al (2022) Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects. Rev Endocr Metab Disord 23(3):647–657. https://doi.org/10.1007/s11154-022-09718-9
Chung TK, Riley KO, Woodworth BA (2015) The use of image-guidance during transsphenoidal pituitary surgery in the United States. Am J Rhinol Allergy 29(3):215–220. https://doi.org/10.2500/ajra.2015.29.4166
Juthani RG, Reiner AS, Patel AR et al (2021) E 1824 134(June):1824–1835. https://doi.org/10.3171/2020.4.JNS20178.J
Cooper O, Bonert V, Liu NA, Mamelak AN (2021) Treatment of aggressive pituitary adenomas: a case-based narrative review. Front Endocrinol (Lausanne) 12(November). https://doi.org/10.3389/fendo.2021.725014
Almeida JP, Ruiz-Treviño AS, Liang B et al (2018) Reoperation for growth hormone–secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 129(2):404–416. https://doi.org/10.3171/2017.2.JNS162673
Benveniste RJ, King WA, Walsh J, Lee JS, Delman BN, Post KD (2005) Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma. J Neurosurg 102(6):1004–1012. https://doi.org/10.3171/jns.2005.102.6.1004
Funding
No funding was used for this manuscript.
Author information
Authors and Affiliations
Contributions
MP, MC, and VT prepared, edited, and reviewed the manuscript and figure.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pease, M., Cohen, M.A. & Tabar, V. Advances in surgical approaches for refractory pituitary adenomas. Pituitary 26, 293–297 (2023). https://doi.org/10.1007/s11102-023-01318-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-023-01318-3